There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
"Ethyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate-d9 is an intermediate in the synthesis of Febuxostat-d9 (F229002). Febuxostat-d9 is the labelled analogue of Febuxostat (F229000). Febuxostat is an Xanthine oxidase/xanthine dehydrogenase inhibitor, used for treatment of hyperuricemia and chronic gout."
Hazard Compound
Refer MSDS for complete information.
Overview
"Ethyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate-d9 is an intermediate in the synthesis of Febuxostat-d9 (F229002). Febuxostat-d9 is the labelled analogue of Febuxostat (F229000). Febuxostat is an Xanthine oxidase/xanthine dehydrogenase inhibitor, used for treatment of hyperuricemia and chronic gout."
![D-[UL-13C5]xylulose](https://structures.clearsynth.com/CS-OC-00019.PNG)
